UTI Healthcare Fund - Regular Plan - Growth Option
₹307.1814
₹2.69 (-0.87%)
NAV as of 29 May 2026
Today's NAV — all variants
Regular · Growth
₹₹307.1814
₹2.69 (-0.87%)
29 May 2026
AMFI: 100807
Direct · Growth
₹₹349.2681
₹3.04 (-0.86%)
29 May 2026
AMFI: 120782
Regular · IDCW
₹₹237.4084
₹2.08 (-0.87%)
29 May 2026
AMFI: 100806
Direct · IDCW
₹₹269.9587
₹2.35 (-0.86%)
29 May 2026
AMFI: 120783
Returns (Lumpsum)
CAGR for periods ≥ 1 yearSIP Returns (XIRR)
₹1,000/month SIP, annualisedSIP since inception — what ₹500/month became
Real NAV backtest from day one
₹1,60,000
Invested
₹17,43,269
Value today
15.1%
XIRR (p.a.)
₹500/month SIP from fund inception · Current value as of today
Try SIP Calculator with this fund's history₹1,000 lumpsum at launch — value today
Invested on the fund's first NAV date
₹1,000
Invested
₹25,749
Value today
12.9%
CAGR (p.a.)
One-time investment at fund inception · Growth purely from NAV appreciation
Try Lumpsum Calculator₹10L corpus with ₹5,000/month withdrawals since inception
Corpus is still growing despite monthly payouts
₹10,00,000
Initial corpus
₹16,00,000
Withdrawn
₹83,15,963
Corpus left
+₹89,15,963 net gain — withdrew ₹16,00,000 AND corpus grew
Plan your SWP with real NAV₹6L corpus via 12-month STP from a liquid fund at inception
₹50K/month transferred from HDFC Liquid → this fund at launch
₹6,00,000
Invested
₹1,61,92,984
Value today
+4.8%
vs lumpsum
STP beat direct lumpsum by 4.8% — reduced timing risk paid off
Model your own STP with real NAVBeat the benchmark — ₹500/month SIP
Same SIP in this fund vs the benchmark index
This fund
₹17,43,269
Benchmark
₹17,02,069
+₹41,200 extra wealth vs the benchmark index
Backtest this SIP yourself₹1 lakh on the worst crash day — 22 Mar 2020
Worst single-day Nifty drop during this fund's life
₹1,00,000
Invested
₹4,16,271
Value today
4.2×
Multiple
Staying invested through that crash turned ₹1L into ₹4,16,271 — a 4.2× return
Read: Staying invested through crashesDirect vs Regular — ₹500/month over 10 years
Expense ratio drag on your actual returns
Direct plan
₹1,17,443
Regular plan
₹1,48,970
Same fund, same NAV history — only the expense ratio differs. Direct plans always outperform Regular over time.
Learn about Direct vs Regular plansFund Details
Risk Metrics
Trailing 1 year, annualised-0.02
Sharpe Ratio
+0.03
Alpha
0.35
Beta
-0.02
Sortino
14.82%
Std Dev
-16.02%
Max Drawdown
Portfolio Holdings
Top 43 holdings · as of Mar 2026
| Security | % NAV |
|---|---|
SUN PHARMACEUTICALS INDUSTRIES INE044A01036 | 9.99% |
AJANTA PHARMA LTD. INE031B01049 | 6.40% |
LUPIN LTD. INE326A01037 | 5.92% |
GLENMARK PHARMACEUTICALS LTD. INE935A01035 | 4.04% |
APOLLO HOSPITALS ENTERPRISE LT INE437A01024 | 3.73% |
GLAND PHARMA LTD. INE068V01023 | 3.46% |
DR REDDYS LABORATORIES LTD. INE089A01031 | 3.45% |
DIVIS LABORATORIES LTD. INE361B01024 | 3.42% |
ALKEM LABORATORIES LTD INE540L01014 | 3.41% |
FORTIS HEALTHCARE LTD. INE061F01013 | 3.01% |
AUROBINDO PHARMA LTD. INE406A01037 | 2.98% |
COHANCE LIFESCIENCES LIMITED INE03QK01018 | 2.76% |
MAX HEALTHCARE INSTITUTE LTD INE027H01010 | 2.63% |
IPCA LABORATORIES LTD. INE571A01038 | 2.38% |
ANTHEM BIOSCIENCES LTD INE0CZ201020 | 2.32% |
PROCTOR & GAMBLE HEALTH LTD INE199A01012 | 2.27% |
JUPITER LIFE LINE HOSPITALS LTD INE682M01012 | 2.19% |
SUDEEP PHARMA LIMITED INE0QPI01025 | 2.14% |
SAI LIFE SCIENCES LTD INE570L01029 | 2.11% |
CAPLIN POINT LABORATORIES LTD INE475E01026 | 2.07% |
ASTER DM HEALTHCARE LTD INE914M01019 | 2.06% |
GLOBAL HEALTH LTD. INE474Q01031 | 1.92% |
VIYASH SCIENTIFIC LTD INE807F01027 | 1.90% |
ERIS LIFESCIENCES LTD INE406M01024 | 1.84% |
CIPLA LTD. INE059A01026 | 1.74% |
PFIZER LIMITED INE182A01018 | 1.72% |
MARKSANS PHARMA LTD. INE750C01026 | 1.69% |
METROPOLIS HEALTHCARE LTD INE112L01020 | 1.59% |
RAINBOW CHILDRENS MEDICARE LTD INE961O01016 | 1.59% |
KRISHNA INSTITUTE OF MEDI SCIE INE967H01025 | 1.36% |
DR LAL PATHLABS LTD. INE600L01024 | 1.24% |
WINDLAS BIOTEC LTD INE0H5O01029 | 1.16% |
VIJAYA DIAGNOSTIC CENTRE LTD INE043W01024 | 1.08% |
EMCURE PHARMACEUTICALS LTD INE168P01015 | 1.05% |
SANOFI CONSUMER HEALTHCARE INDIA LTD INE0UOS01011 | 0.98% |
AARTI PHARMALABS LTD INE0LRU01027 | 0.84% |
JUBILANT PHARMOVA LIMITED INE700A01033 | 0.69% |
BIOCON LTD. INE376G01013 | 0.68% |
SYNGENE INTERNATIONAL LTD. INE398R01022 | 0.66% |
ACUTAAS CHEMICALS LIMITED INE00FF01025 | 0.61% |
LAXMI DENTAL LIMITED INE0WO601020 | 0.60% |
ALEMBIC PHARMACEUTICALS INE901L01018 | 0.52% |
ORCHID PHARMA LTD. INE191A01027 | 0.46% |
Performance Comparison
Interested in This Fund?
Our experts will help you decide if this fund fits your goals.
Compare with Similar Funds
Investment Objective
UTI Healthcare Fund - Regular Plan - Growth Option invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
UTI Healthcare Fund - Regular Plan - Growth Option is a Sectoral / Thematic mutual fund offered by UTI Mutual Fund. The fund has been operational for over 26 years. It manages assets worth ₹1,080 Cr, reflecting investor confidence in the fund's strategy. It benchmarks its performance against BSE Healthcare TRI. The current expense ratio is 2.27%.
Who Should Invest?
- •Aggressive investors comfortable with significant short-term volatility
- •Investors with a long-term horizon of 7+ years who can ride out market cycles
- •SIP investors who can benefit from rupee cost averaging during market fluctuations